Stress, depression and cardiovascular dysregulation: A review of neurobiological mechanisms and the integration of research from preclinical disease models

Bidirectional associations between mood disorders and cardiovascular diseases are extensively documented. However, the precise physiological and biochemical mechanisms that underlie such relationships are not well understood. This review focuses on the neurobiological processes and mediators that are common to both mood and cardiovascular disorders. The discussion places an emphasis on the role of exogenous stressors in addition to: (a) neuroendocrine and neurohumoral changes involving dysfunction of the hypothalamic-pituitary-adrenal axis and the activation of the renin-angiotensin-aldosterone system, (b) immune alterations including activation of pro-inflammatory cytokines, (c) autonomic and cardiovascular dysregulation including increased sympathetic drive, withdrawal of parasympathetic tone, cardiac rate and rhythm disturbances, and altered baroreceptor reflex function, (d) central neurotransmitter system dysfunction involving the dopamine, norepinephrine and serotonin systems, and (e) behavioral changes including fatigue and physical inactivity. The review also discusses experimental investigations using preclinical disease models to elucidate the neurobiological mechanisms underlying the link between mood disorders and cardiovascular disease. These include: (a) the chronic mild stress model of depression, (b) a model of congestive heart failure, (c) a model of cardiovascular deconditioning, (d) pharmacological manipulations of body fluid and sodium balance, and (e) pharmacological manipulations of the central serotonergic system. In combination with an extensive human research literature, the investigation of mechanisms underlying mood and cardiovascular regulation using animal models will enhance understanding the association between depression and cardiovascular disease. This will ultimately promote the development of better treatments and interventions for individuals with co-morbid psychological and somatic pathologies.

[1]  R. D. L. Garza.  Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia , 2005, Neuroscience & Biobehavioral Reviews.

[2]  H. Berendsen,et al.  Interactions between 5-hydroxytryptamine receptor subtypes: is a disturbed receptor balance contributing to the symptomatology of depression in humans? , 1995, Pharmacology & therapeutics.

[3]  C. Zarins,et al.  Retarding effect of lowered heart rate on coronary atherosclerosis. , 1984, Science.

[4]  N. Frasure-smith,et al.  Depression and 18-month prognosis after myocardial infarction. , 1995, Circulation.

[5]  H. Besedovsky,et al.  Interleukin-1 stimulates aldosterone secretion: involvement of renin, ACTH, and prostaglandins. , 1992, The American journal of physiology.

[6]  D. Gemsa,et al.  Effects of interferon-γ, interleukin-1β, and tumor necrosis factor-α on the serotonin metabolism in the nucleus raphe dorsalis of the rat , 2005, Journal of Neural Transmission.

[7]  D. Murphy,et al.  Neuroendocrine responses to serotonergic agonists as indices of the functional status of central serotonin neurotransmission in humans: A preliminary comparative analysis of neuroendocrine endpoints versus other endpoint measures , 1995, Behavioural Brain Research.

[8]  J. Krueger,et al.  Sleep-promoting effects of endogenous pyrogen (interleukin-1). , 1984, The American journal of physiology.

[9]  A. Johnson,et al.  Reduced hedonic behavior and altered cardiovascular function induced by mild sodium depletion in rats. , 2006, Behavioral neuroscience.

[10]  P. Goodnick,et al.  Chronic Fatigue and Related Immune Deficiency Syndromes , 1993 .

[11]  J. Lawler,et al.  The borderline hypertensive rat (BHR) as a model for environmentally-induced hypertension: A review and update , 1992, Neuroscience & Biobehavioral Reviews.

[12]  A. Moss,et al.  Psychosocial aspects of sudden death. A preliminary report. , 1972, Archives of internal medicine.

[13]  A. Dunn,et al.  Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. , 1999, Advances in experimental medicine and biology.

[14]  J. Francis,et al.  Mineralocorticoids act centrally to regulate blood-borne tumor necrosis factor-alpha in normal rats. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[15]  B. Penninx,et al.  Depression and cardiac mortality: results from a community-based longitudinal study. , 2001, Archives of general psychiatry.

[16]  J. Harding,et al.  The Angiotensin IV System: Functional Implications , 1995, Frontiers in Neuroendocrinology.

[17]  R. Weiss,et al.  Central mineralocorticoid receptor blockade decreases plasma TNF-alpha after coronary artery ligation in rats. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[18]  I. Kusumi,et al.  Serotonin-stimulated Ca2+ response is increased in the blood platelets of depressed patients , 1991, Biological Psychiatry.

[19]  Phyllis K. Stein,et al.  Association of depression witk reduced heart rate variability in coronary artery disease , 1995 .

[20]  M. Bedi,et al.  ROLE OF CARDIOVASCULAR REACTIVITY TO MENTAL STRESS IN PREDICTING FUTURE HYPERTENSION , 2000, Clinical and experimental hypertension.

[21]  R. Weiss,et al.  Cytokine mediation of experimental heart failure-induced anhedonia. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[22]  I. Lucki,et al.  Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test , 2005, Neuroscience & Biobehavioral Reviews.

[23]  R. Carney,et al.  Ventricular tachycardia and psychiatric depression in patients with coronary artery disease. , 1993, The American journal of medicine.

[24]  R. Carney,et al.  Depression as a risk factor for cardiac events in established coronary heart disease: A review of possible mechanisms , 1995, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[25]  L. Kaplan,et al.  Carotenoid composition, concentrations, and relationships in various human organs. , 1990, Clinical physiology and biochemistry.

[26]  P. Siltanen,et al.  Premonitory symptoms and stress factors preceding sudden death from ischaemic heart disease. , 2009, Acta medica Scandinavica.

[27]  A. Ostfeld,et al.  Prospective and Retrospective Psychological Studies of Coronary Heart Disease , 1967, Psychosomatic medicine.

[28]  L. Kar.  Neuroendocrine aspects of the serotonergic hypothesis of depression , 1989, Neuroscience & Biobehavioral Reviews.

[29]  C. Maroun,et al.  Distinct roles for CD4 and CD8 as co-receptors in antigen receptor signalling. , 1993, Immunology today.

[30]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[31]  E. Gomez-Sanchez.  Brain mineralocorticoid receptors: orchestrators of hypertension and end-organ disease , 2004, Current opinion in nephrology and hypertension.

[32]  T. LeJemtel,et al.  Vasopressin dysregulation: hyponatremia, fluid retention and congestive heart failure. , 2007, International journal of cardiology.

[33]  P. Grøttum,et al.  Beneficial effects of vagal stimulation on the ischaemic myocardium during beta-receptor blockade. , 1981, Scandinavian journal of clinical and laboratory investigation.

[34]  R. Weiss,et al.  Progression of heart failure after myocardial infarction in the rat. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[35]  W. Banks,et al.  Passage of cytokines across the blood-brain barrier. , 1995, Neuroimmunomodulation.

[36]  I. Heuser,et al.  Increased diurnal plasma concentrations of cortisone in depressed patients. , 2000, The Journal of clinical endocrinology and metabolism.

[37]  D. Laude,et al.  Specific Serotonin Reuptake Inhibition in Major Depressive Disorder Adversely Affects Novel Markers of Cardiac Risk , 2007, Hypertension Research.

[38]  D. Watson,et al.  Negative affectivity: the disposition to experience aversive emotional states. , 1984, Psychological bulletin.

[39]  C. Nemeroff,et al.  The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. , 1998, Archives of general psychiatry.

[40]  Principles of the Pharmacotherapy of Depression , 2011 .

[41]  A. Nosjean,et al.  Increased sympathetic nerve discharge without alteration in the sympathetic baroreflex response by serotonin3 receptor stimulation in the nucleus tractus solitarius of the rat , 1995, Neuroscience Letters.

[42]  D. Morilak,et al.  Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders. , 2004, The international journal of neuropsychopharmacology.

[43]  B. Gutiérrez,et al.  Association study between novel promoter variants at the 5-HT2C receptor gene and human patients with bipolar affective disorder , 2001, Neuroscience Letters.

[44]  M. Fletcher,et al.  Immunological Correlates of Chronic Fatigue Syndrome , 1993 .

[45]  K. Ressler,et al.  Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders , 2000, Depression and anxiety.

[46]  R. Califf,et al.  Depression and long-term mortality risk in patients with coronary artery disease. , 1996, The American journal of cardiology.

[47]  B. Leonard,et al.  Depression, stress and immunological activation: the role of cytokines in depressive disorders. , 1998, Life sciences.

[48]  J. House,et al.  Depressive Symptoms and Mortality Risk in a National Sample: Confounding Effects of Health Status , 2004, Psychosomatic medicine.

[49]  J. Lawler,et al.  Ventricular electrical instability in the conscious dog: effects of psychologic stress and beta adrenergic blockade. , 1976, The American journal of cardiology.

[50]  M. Esler,et al.  The peripheral kinetics of norepinephrine in depressive illness. , 1982, Archives of general psychiatry.

[51]  R. Weiss,et al.  Heart failure and the brain: new perspectives. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[52]  N. Rothwell,et al.  Cytokines and the nervous system I: expression and recognition , 1995, Trends in Neurosciences.

[53]  A. Appels,et al.  Excess fatigue as a precursor of myocardial infarction. , 1988, European heart journal.

[54]  A. Glassman.  Depression and cardiovascular comorbidity , 2007, Dialogues in clinical neuroscience.

[55]  G. Blauw,et al.  Pathophysiological and pharmacotherapeutic aspects of serotonin and serotonergic drugs. , 1990, Clinical physiology and biochemistry.

[56]  K. Airaksinen.  Autonomic mechanisms and sudden death after abrupt coronary occlusion. , 1999, Annals of medicine.

[57]  H. Besedovsky,et al.  Interleukin-1 induces changes in norepinephrine metabolism in the rat brain , 1988, Brain, Behavior, and Immunity.

[58]  B. Carroll.  Limbic System‐Adrenal Cortex Regulation in Depression and Schizophrenia , 1976, Psychosomatic medicine.

[59]  R. Dantzer,et al.  Differential effects of inescapable footshocks and of stimuli previously paired with inescapable footshocks on dopamine turnover in cortical and limbic areas of the rat. , 1982, Life sciences.

[60]  M. Rietschel,et al.  Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder , 2000, Molecular Psychiatry.

[61]  N. Frasure-smith,et al.  Depression following myocardial infarction. Impact on 6-month survival. , 1993, JAMA.

[62]  P. Willner.  The mesolimbic dopamine system as a target for rapid antidepressant action , 1997, International clinical psychopharmacology.

[63]  P. Brain,et al.  Effects of chronic mild stress (CMS) and imipramine administration, on spleen mononuclear cell proliferative response, serum corticosterone level and brain norepinephrine content in male mice , 1999, Psychoneuroendocrinology.

[64]  J. Vaidya,et al.  A Comparative Developmental Study of Impulsivity in Rats and Humans: The Role of Reward Sensitivity , 2004, Annals of the New York Academy of Sciences.

[65]  A. K. Johnson,et al.  The Neuroendocrinology, Neurochemistry and Molecular Biology of Thirst and Salt Appetite , 2007 .

[66]  N. McCartney.  Role of resistance training in heart disease. , 1998, Medicine and science in sports and exercise.

[67]  F. Bloom,et al.  Psychopharmacology: The Fourth Generation of Progress , 1995 .

[68]  Kevin D. Wu,et al.  Social isolation in prairie voles induces behaviors relevant to negative affect: toward the development of a rodent model focused on co‐occurring depression and anxiety , 2008, Depression and anxiety.

[69]  S. Kimmel,et al.  Effect of Antidepressants and Their Relative Affinity for the Serotonin Transporter on the Risk of Myocardial Infarction , 2003, Circulation.

[70]  J. Salonen,et al.  Hopelessness and Risk of Mortality and Incidence of Myocardial Infarction and Cancer , 1996, Psychosomatic medicine.

[71]  M. Vaidya,et al.  Cytokeratin expression in human fetal tongue and buccal mucosa , 2000, Journal of Biosciences.

[72]  R. van Diest,et al.  Vital exhaustion and depression: a conceptual study. , 1991, Journal of psychosomatic research.

[73]  F. Cambien,et al.  Serotonin Transporter Gene Polymorphism and Myocardial Infarction: Etude Cas-Témoins de l’Infarctus du Myocarde (ECTIM) , 2002, Circulation.

[74]  I. Lucki,et al.  The spectrum of behaviors influenced by serotonin , 1998, Biological Psychiatry.

[75]  D. Swaab,et al.  The stress system in the human brain in depression and neurodegeneration , 2005, Ageing Research Reviews.

[76]  J. Ak,et al.  Sadness and broken hearts: neurohumoral mechanisms and co-morbidity of ischemic heart disease and psychological depression. , 2006 .

[77]  S. Knardahl,et al.  Effects of adrenal demedullation on stress-induced hypertension and cardiovascular responses to acute stress. , 1988, Acta physiologica Scandinavica.

[78]  J. Morley,et al.  Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects , 1988, Brain Research.

[79]  T. Rechlin,et al.  Heart Rate Variability in Depressed Patients and Differential Effects of Paroxetine and Amitriptyline on Cardiovascular Autonomic Functions , 1994, Pharmacopsychiatry.

[80]  A. Armario,et al.  Chronic Stress Increases Serotonin and Noradrenaline in Rat Brain and Sensitizes Their Responses to a Further Acute Stress , 1988, Journal of neurochemistry.

[81]  H. Praag,et al.  Can stress cause depression? , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[82]  W. Fenton,et al.  Mood disorders: cardiovascular and diabetes comorbidity , 2006, Current opinion in psychiatry.

[83]  Michael Maes,et al.  Evidence for an immune response in major depression: A review and hypothesis , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[84]  C. Nemeroff,et al.  Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. , 1994, Clinical chemistry.

[85]  H. Anisman,et al.  Multiple neurochemical and behavioral consequences of stressors: implications for depression. , 1990, Pharmacology & therapeutics.

[86]  M. Esler,et al.  Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. , 2000, Journal of cardiovascular pharmacology.

[87]  R. Weiss,et al.  Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. , 2001, American journal of physiology. Heart and circulatory physiology.

[88]  A. K. Johnson,et al.  Sadness and broken hearts: neurohumoral mechanisms and co-morbidity of ischemic heart disease and psychological depression. , 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[89]  C. Nemeroff,et al.  CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse , 1992, European Neuropsychopharmacology.

[90]  G. Battaglia,et al.  Long-term fluoxetine produces behavioral anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats , 2000, Brain Research.

[91]  E. Badoer.  Proceedings of the Australian Physiological and Pharmacological Society Symposium: The Hypothalamus HYPOTHALAMIC PARAVENTRICULAR NUCLEUS AND CARDIOVASCULAR REGULATION , 2001 .

[92]  C. Stier,et al.  Aldosterone as a Mediator in Cardiovascular Injury , 2002, Cardiology in review.

[93]  A. Johnson,et al.  The effects of deoxycorticosterone-induced sodium appetite on hedonic behaviors in the rat. , 2006, Behavioral neuroscience.

[94]  H. Anisman,et al.  Sensitization of norepinephrine activity following acute and chronic footshock , 1986, Brain Research.

[95]  H. Friedman,et al.  Psychological predictors of heart disease: a quantitative review. , 1987, Psychological bulletin.

[96]  I. Tobler,et al.  Interleukin-1 derived from astrocytes enhances slow wave activity in sleep EEG of the rat. , 1984, European journal of pharmacology.

[97]  Rungroj Krittayaphong,et al.  Heart Rate Variability in Patients with Coronary Artery Disease: Differences in Patients with Higher and Lower Depression Scores , 1997, Psychosomatic medicine.

[98]  R. Carney,et al.  Major depressive disorder predicts cardiac events in patients with coronary artery disease. , 1988, Psychosomatic medicine.

[99]  M. Karnovsky,et al.  Intimal alterations in rat aorta induced by stressful stimuli. , 1981, Laboratory investigation; a journal of technical methods and pathology.

[100]  C. Nemeroff,et al.  Depression and cardiac disease , 1998, Depression and anxiety.

[101]  H A Lindberg,et al.  Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. , 1980, American journal of epidemiology.

[102]  R. Dantzer.  How do cytokines say hello to the brain? Neural versus humoral mediation. , 1994, European cytokine network.

[103]  M. Papp,et al.  Antidepressant-like effects of dopamine agonists in an animal model of depression , 1992, Biological Psychiatry.

[104]  P. Willner.  Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation , 1997, Psychopharmacology.

[105]  K. Cantell,et al.  Behavioral assessment of patients treated with alpha‐interferon , 1988, Acta psychiatrica Scandinavica.

[106]  U. Das.  Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction , 2000, Molecular and Cellular Biochemistry.

[107]  W. Vale,et al.  Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat , 1983, Nature.

[108]  P. Rizzon,et al.  Depression but not anxiety influences the autonomic control of heart rate after myocardial infarction. , 2001, American heart journal.

[109]  W. Kaschka,et al.  Are affective disorders associated with alterations of heart rate variability? , 1994, Journal of affective disorders.

[110]  D. Musselman,et al.  Depression, alterations in platelet function, and ischemic heart disease. , 2005, Psychosomatic medicine.

[111]  S. Maier,et al.  Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. , 1998, Psychological review.

[112]  W. Catterall,et al.  Interactions of neurotoxins with the action potential NA + ionophore. , 1976, Journal of supramolecular structure.

[113]  L. Swanson,et al.  Paraventricular nucleus: a site for the integration of neuroendocrine and autonomic mechanisms. , 1980, Neuroendocrinology.

[114]  M. H. Joseph,et al.  Stress-induced release of 5-HT in the hippocampus and its dependence on increased tryptophan availability: an in vivo electrochemical study , 1983, Brain Research.

[115]  R. Weiss,et al.  Neurohumoral regulation in ischemia-induced heart failure: Role of the forebrain , 2001, Autonomic Neuroscience.

[116]  A. Dunn,et al.  Effects of Cytokines on Cerebral Neurotransmission , 1999 .

[117]  H. V. van Hout,et al.  Depression and the risk for cardiovascular diseases: systematic review and meta analysis , 2007, International journal of geriatric psychiatry.

[118]  R. S. Smith.  The macrophage theory of depression. , 1991, Medical hypotheses.

[119]  A. Johnson,et al.  Cardiovascular alterations and autonomic imbalance in an experimental model of depression. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[120]  T. Seeman,et al.  The impact of depressive symptomatology on physical disability: MacArthur Studies of Successful Aging. , 1994, American journal of public health.

[121]  V. Vaidya.  Stress, depression and hippocampal damage. , 2000, Journal of biosciences.

[122]  Y. Pollak,et al.  Cytokine-induced changes in mood and behaviour: implications for 'depression due to a general medical condition', immunotherapy and antidepressive treatment. , 2002, The international journal of neuropsychopharmacology.

[123]  S. Guthrie,et al.  Plasma norepinephrine responses to cold challenge in depressed patients and normal controls , 1987, Psychiatry Research.

[124]  C. Nemeroff,et al.  Epidemiology of comorbid coronary artery disease and depression , 2003, Biological Psychiatry.

[125]  P. Willner,et al.  “Depression” increases “craving” for sweet rewards in animal and human models of depression and craving , 1998, Psychopharmacology.

[126]  H. Anisman,et al.  Depression: The predisposing influence of stress , 1982, Behavioral and Brain Sciences.

[127]  Richard De La Garza,et al.  Involvement of 5-HT1A receptors in animal tests of anxiety and depression: evidence from genetic models. , 2003, Stress.

[128]  M. Mikuni,et al.  Increased 5-HT-2 receptor function as measured by serotonin-stimulated phosphoinositide hydrolysis in platelets of depressed patients. , 1991, Progress in neuro-psychopharmacology & biological psychiatry.

[129]  P. Shapiro,et al.  Depression and the course of coronary artery disease. , 1998, The American journal of psychiatry.

[130]  W. Alexander.  American psychiatric association. , 2008, P & T : a peer-reviewed journal for formulary management.

[131]  I. Hickie,et al.  The Psychiatric Status of Patients with the Chronic Fatigue Syndrome , 1990, British Journal of Psychiatry.

[132]  L. Hawkley,et al.  Loneliness , dysphoria , stress and immunity : A role for cytokines , 2007 .

[133]  S. Feldman,et al.  Depletion of hypothalamic norepinephrine and serotonin enhances the dexamethasone negative feedback effect on adrenocortical secretion , 1991, Psychoneuroendocrinology.

[134]  F. Lechin,et al.  Plasma neurotransmitters, blood pressure, and heart rate during supine-resting, orthostasis, and moderate exercise conditions in major depressed patients , 1995, Biological Psychiatry.

[135]  R. Dantzer.  Cytokine, sickness behavior, and depression. , 2006, Neurologic clinics.

[136]  P. Schwartz,et al.  Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. , 1988, Circulation.

[137]  Y. Pelloux,et al.  Helplessness in the tail suspension test is associated with an increase in ethanol intake and its rewarding effect in female mice. , 2005, Alcoholism, clinical and experimental research.

[138]  M. Schroll,et al.  Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. , 1996, Circulation.

[139]  John M. Davis,et al.  Platelet serotonin-2 receptor binding sites in depression and suicide , 1990, Biological Psychiatry.

[140]  R. Carney,et al.  Association of depression with reduced heart rate variability in coronary artery disease. , 1995, The American journal of cardiology.

[141]  A. Johnson,et al.  Behavioral and cardiovascular changes in the chronic mild stress model of depression , 2003, Physiology & Behavior.

[142]  M. L. Blair,et al.  Forebrain Pathways Mediating Stress-Induced Hormone Secretion , 1999, Frontiers in Neuroendocrinology.

[143]  R. Carney,et al.  Change in Heart Rate and Heart Rate Variability During Treatment for Depression in Patients With Coronary Heart Disease , 2000, Psychosomatic medicine.

[144]  A. Steiger,et al.  The Renin-Angiotensin-Aldosterone system in patients with depression compared to controls – a sleep endocrine study , 2003, BMC psychiatry.

[145]  A. Dunn,et al.  Cytokines as mediators of depression: What can we learn from animal studies? , 2005, Neuroscience & Biobehavioral Reviews.

[146]  J. Mendels,et al.  Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients. , 1976, Archives of general psychiatry.

[147]  P. Grossman,et al.  Association of depressive symptoms with reduced baroreflex cardiac control in coronary artery disease. , 1999, American heart journal.

[148]  R. Carney,et al.  Can treating depression reduce mortality after an acute myocardial infarction? , 1999, Psychosomatic medicine.

[149]  Andrew E. Skodol,et al.  DSM-IV-TR Casebook: A Learning Companion to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision , 2001 .

[150]  R. Weiss,et al.  The Effects of Chronic Fluoxetine Treatment on Chronic Mild Stress-Induced Cardiovascular Changes and Anhedonia , 2006, Biological Psychiatry.

[151]  H. Anisman,et al.  Depression as a Consequence of Inadequate Neurochemical Adaptation in Response to Stressors , 1992, British Journal of Psychiatry.

[152]  G D Pinna,et al.  Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications. , 1997, Circulation.

[153]  M. Condorelli,et al.  Effects of coronary occlusion on arterial baroreflex control of heart rate and vascular resistance. , 1987, The American journal of physiology.

[154]  J. Puffer,et al.  Depression and chronic fatigue in athletes. , 1992, Clinics in sports medicine.

[155]  The Healing Mind , 1975 .

[156]  A. Johnson,et al.  Increased susceptibility to ventricular arrhythmias in a rodent model of experimental depression. , 2004, American journal of physiology. Heart and circulatory physiology.

[157]  E. Zorrilla,et al.  The Relationship of Depression and Stressors to Immunological Assays: A Meta-Analytic Review , 2001, Brain, Behavior, and Immunity.

[158]  R. H. Chaney,et al.  Cardiovascular changes during acute depression. , 1980, Psychosomatics.

[159]  A. Ehlis,et al.  Consensus paper of the WFSBP Task Force on Biological Markers: Biological Markers in Depression , 2007, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[160]  A. Sgoifo,et al.  Cardiac autonomic responses to intermittent social conflict in rats , 2001, Physiology & Behavior.

[161]  Bidzińska Ej.  Stress factors in affective diseases. , 1984 .

[162]  R. Fuller.  Serotonin receptors involved in regulation of pituitary-adrenocortical function in rats , 1995, Behavioural Brain Research.

[163]  H. L. Stone,et al.  Baroreceptor Reflex Control of Heart Rate: A Predictor of Sudden Cardiac Death , 1982, Circulation.

[164]  M. Wichers,et al.  The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. , 2002, The international journal of neuropsychopharmacology.

[165]  M. Szegedy-Maszak,et al.  Hearts and minds. , 2003, U.S. news & world report.

[166]  H. Fillit,et al.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.

[167]  J. Miller,et al.  Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. , 1987, The American journal of cardiology.

[168]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[169]  F. Holsboer,et al.  Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? , 1995, Trends in Neurosciences.

[170]  R. Ferrari,et al.  The role of TNF in cardiovascular disease. , 1999, Pharmacological research.

[171]  Matthew Hotopf,et al.  Chronic fatigue syndrome , 2010, BMJ : British Medical Journal.

[172]  S. D. de Boer,et al.  Vulnerability to arrhythmias during social stress in rats with different sympathovagal balance. , 1998, American journal of physiology. Heart and circulatory physiology.

[173]  P. Willner,et al.  Stereospecific reversal of stress-induced anhedonia by mianserin and its (+)-enantiomer , 1994, Psychopharmacology.

[174]  G. Fonarow,et al.  Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. , 2007, European heart journal.

[175]  P. Britton,et al.  CHAPTER 10 – The Minnesota Multiphasic Personality Inventory , 1966 .

[176]  B. Pitt,et al.  The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .

[177]  Alan D. Lopez,et al.  The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .

[178]  V. Ld,et al.  Serotonin and the Neuroendocrine Regulation of the Hypothalamic–Pituitary–Adrenal Axis in Health and Disease , 2003 .

[179]  G. Bagdy,et al.  Hypothalamic paraventricular nucleus lesions differentially affect serotonin-1A (5-HT1A) and 5-HT2 receptor agonist-induced oxytocin, prolactin, and corticosterone responses. , 1994, Endocrinology.

[180]  R. Carney,et al.  The relationship between heart rate, heart rate variability and depression in patients with coronary artery disease. , 1988, Journal of psychosomatic research.

[181]  B. Pitt,et al.  Spironolactone treatment and clinical outcomes in patients with systolic dysfunction and mild heart failure symptoms: a retrospective analysis. , 2006, Journal of cardiac failure.

[182]  L. D. van de Kar.  Neuroendocrine aspects of the serotonergic hypothesis of depression. , 1989, Neuroscience and biobehavioral reviews.

[183]  R. Verrier,et al.  Behavioral stress and cardiac arrhythmias. , 1984, Annual review of physiology.

[184]  E. D. De Souza,et al.  Interleukin 1 receptors in the brain and endocrine tissues. , 1993, Immunology today.

[185]  R. Weiss,et al.  Neurohumoral Regulation in Ischemia‐Induced Heart Failure , 2001 .

[186]  R. Verrier,et al.  Psychological stress and ventricular arrhythmias during myocardial infarction in the conscious dog. , 1974, The American journal of cardiology.

[187]  V. O’Keane,et al.  Depression and interferon-alpha therapy , 2000, British Journal of Psychiatry.

[188]  P. Guyenet,et al.  Role of serotonin and catecholamines in sympathetic responses evoked by stimulation of rostral medulla. , 1994, The American journal of physiology.

[189]  B. Roth.  Multiple serotonin receptors: clinical and experimental aspects. , 1994, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[190]  M. Fletcher,et al.  Immunologic abnormalities in chronic fatigue syndrome , 1990, Journal of clinical microbiology.

[191]  D. Goldstein,et al.  Plasma catecholamines and essential hypertension. An analytical review. , 1983, Hypertension.

[192]  C. Nathan,et al.  Secretory products of macrophages. , 1987, The Journal of clinical investigation.

[193]  L. Lanfumey,et al.  Neurochemical and Behavioral Alterations in Glucocorticoid Receptor-Impaired Transgenic Mice after Chronic Mild Stress , 2004, The Journal of Neuroscience.

[194]  C. Lyketsos,et al.  Mood Disorders in the Medically Ill: Scientific Review and Recommendations , 2005, Biological Psychiatry.

[195]  J. E. Skinner,et al.  Coronary flow and mental stress. Experimental findings. , 1991, Circulation.

[196]  S. Julius,et al.  Association of tachycardia with morbidity and mortality: pathophysiological considerations. , 1997, Journal of human hypertension.

[197]  J. Bigger,et al.  Cardiovascular effects of fluoxetine in depressed patients with heart disease. , 1998, The American journal of psychiatry.

[198]  J. Mendels,et al.  Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction. , 1976, Archives of general psychiatry.

[199]  H. Meltzer.  Role of Serotonin in Depression a , 1990, Annals of the New York Academy of Sciences.

[200]  Jerry Suls,et al.  Anger, anxiety, and depression as risk factors for cardiovascular disease: the problems and implications of overlapping affective dispositions. , 2005, Psychological bulletin.

[201]  K. Kisters,et al.  Addressing sympathetic overactivity in major depressive disorder. , 2007, Journal of hypertension.

[202]  E. Badoer.  Hypothalamic paraventricular nucleus and cardiovascular regulation. , 2001, Clinical and experimental pharmacology & physiology.

[203]  S. DiCarlo,et al.  Daily exercise attenuates the sympathetic component of the arterial baroreflex control of heart rate. , 1997, American journal of physiology. Heart and circulatory physiology.

[204]  J. Francis,et al.  Mineralocorticoids act centrally to regulate blood-borne tumor necrosis factor-α in normal rats , 2003 .

[205]  N. Ryan,et al.  The relationship of the dexamethasone suppression test (1 mg and 2 mg) to basal plasma cortisol levels in endogenous depression , 1987, Psychoneuroendocrinology.

[206]  V. Klimek,et al.  Elevated Concentrations of CRF in the Locus Coeruleus of Depressed Subjects , 2003, Neuropsychopharmacology.

[207]  R. Ferrari,et al.  Prognostic benefits of heart rate reduction in cardiovascular disease , 2003 .

[208]  B. Bozkurt,et al.  The role of cytokines in the failing human heart. , 1998, Cardiology clinics.

[209]  M. Wong,et al.  Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[210]  P. Gold,et al.  Corticotropin releasing hormone produces profound anorexigenic effects in the rhesus monkey , 1991, Neuropeptides.

[211]  J. Francis,et al.  Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia , 2005, Physiology & Behavior.

[212]  A. Johnson,et al.  Short-term fluoxetine treatment enhances baroreflex control of sympathetic nervous system activity after hindlimb unloading. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[213]  M. Hollenberg,et al.  Impaired parasympathetic responses in patients after myocardial infarction. , 1976, The American journal of cardiology.

[214]  S. Maier,et al.  Stressor controllability and learned helplessness: The roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor , 2005, Neuroscience & Biobehavioral Reviews.

[215]  E. Bosmans,et al.  Increased 24‐hour urinary cortisol excretion in patients with post‐traumatic stress disorder and patients with major depression, but not h patients with fibromyalgia , 1998, Acta psychiatrica Scandinavica.

[216]  N. R. Hanley,et al.  Serotonin and the neuroendocrine regulation of the hypothalamic--pituitary-adrenal axis in health and disease. , 2003, Vitamins and hormones.

[217]  S. Ross,et al.  Evidence for involvement of 5-hydroxytryptamine(1B) autoreceptors in the enhancement of serotonin turnover in the mouse brain following repeated treatment with fluoxetine. , 2002, Life sciences.

[218]  David D. Shin,et al.  Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial , 2007, Acute cardiac care.

[219]  Z. Kronfol.  Immune dysregulation in major depression: a critical review of existing evidence. , 2002, The international journal of neuropsychopharmacology.

[220]  R. Gorlin,et al.  The nature and course of depression following myocardial infarction. , 1989, Archives of internal medicine.

[221]  Christianna S. Williams,et al.  Depression and risk of coronary heart disease in elderly men and women: New Haven EPESE, 1982-1991. Established Populations for the Epidemiologic Studies of the Elderly. , 1998, Archives of internal medicine.

[222]  D F Swaab,et al.  Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. , 1995, The American journal of psychiatry.

[223]  Mikuni Masahiko,et al.  Increased 5-HT-2 receptor function as measured by serotonin-stimulated phosphoinositide hydrolysis in platelets of depressed patients , 1991, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[224]  R. Weiss,et al.  Neural regulation of the proinflammatory cytokine response to acute myocardial infarction. , 2004, American journal of physiology. Heart and circulatory physiology.

[225]  D. Morilak,et al.  What should animal models of depression model? , 2005, Neuroscience & Biobehavioral Reviews.

[226]  Elisabeth J. Bidzińska.  Stress Factors in Affective Diseases , 1984, British Journal of Psychiatry.

[227]  B Lown,et al.  Neural activity and ventricular fibrillation. , 1976, The New England journal of medicine.

[228]  J. Bigger,et al.  Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction , 1998, The Lancet.

[229]  M. Esler,et al.  Sympathetic Activity in Major Depressive Disorder: Identifying Those at Increased Cardiac Risk? , 2007, Journal of hypertension.

[230]  P. Willner.  Chronic Mild Stress (CMS) Revisited: Consistency and Behavioural-Neurobiological Concordance in the Effects of CMS , 2005, Neuropsychobiology.

[231]  Q. Regestein,et al.  Basis for recurring ventricular fibrillation in the absence of coronary heart disease and its management. , 1976, The New England journal of medicine.

[232]  R. Wolk.  Central origin of decreased heart rate variability in patients with cardiovascular diseases. , 1996, Medical hypotheses.

[233]  D. Tepper,et al.  Characterization and Prognostic Value of Persistent Hyponatremia in Patients With Severe Heart Failure in the ESCAPE Trial , 2008 .

[234]  M. C. Crim,et al.  Effects of high-intensity strength training on quality-of-life parameters in cardiac rehabilitation patients. , 1997, The American journal of cardiology.

[235]  R S Paffenbarger,et al.  Heart rate and cardiovascular mortality: the Framingham Study. , 1987, American heart journal.

[236]  E. Bleuler,et al.  Mood disorders. , 1984, American family physician.

[237]  A. Awad,et al.  Psychopharmacology: The Fourth Generation of Progress , 1998, CNS Spectrums.

[238]  P. Blier,et al.  Pharmacology of rapid-onset antidepressant treatment strategies. , 2001, The Journal of clinical psychiatry.

[239]  H. Huikuri,et al.  Fractal analysis of heart rate variability and mortality after an acute myocardial infarction. , 2002, The American journal of cardiology.

[240]  J. Crane,et al.  Chronic mild stress induces behavioral and physiological changes, and may alter serotonin 1A receptor function, in male and cycling female rats , 2005, Psychopharmacology.

[241]  R. Carney,et al.  Prevalence of Depression in Hospitalized Patients With Congestive Heart Failure , 2003, Psychosomatic medicine.

[242]  E Kristal-Boneh,et al.  Heart rate variability in health and disease. , 1995, Scandinavian journal of work, environment & health.

[243]  Mayumi Okuda Benavides.  Reseña de "Updated Projections of Global Mortality and Burden ofDisease, 2002-2030: Data Sources, Methods and Results" de Mathers CD, Loncar D. Geneva , 2006 .

[244]  K. Freedland,et al.  The Great Debate, revisited. , 2006, Psychosomatic medicine.

[245]  M. Sole,et al.  The identification of specific serotonergic nuclei inhibited by cardiac vagal afferents during acute myocardial ischemia in the rat , 1983, Brain Research.

[246]  E. Eaker,et al.  Depressed Affect, Hopelessness, and the Risk of Ischemic Heart Disease in a Cohort of U.S. Adults , 1993, Epidemiology.

[247]  D. Kufe,et al.  Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study. , 1988, Journal of the National Cancer Institute.

[248]  N. Frasure-smith,et al.  Depression and other psychological risks following myocardial infarction. , 2003, Archives of general psychiatry.

[249]  R. Kast,et al.  Bupropion: pharmacology and therapeutic applications , 2006, Expert review of neurotherapeutics.

[250]  R. De La Garza.  Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia. , 2005, Neuroscience and biobehavioral reviews.

[251]  H. V. van Praag,et al.  Can stress cause depression? , 2005, Progress in neuro-psychopharmacology & biological psychiatry.

[252]  A. Perski,et al.  Intensive rehabilitation of emotionally distressed patients after coronary by‐pass grafting , 1999, Journal of internal medicine.

[253]  P. Sawchenko,et al.  Distinct Brain Vascular Cell Types Manifest Inducible Cyclooxygenase Expression as a Function of the Strength and Nature of Immune Insults , 2002, The Journal of Neuroscience.

[254]  H. Anisman,et al.  An assessment of the effects of central interleukin-1β, -2, -6, and tumor necrosis factor-α administration on some behavioural, neurochemical, endocrine and immune parameters in the rat , 1998, Neuroscience.

[255]  B. Pollock,et al.  Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. , 1998, JAMA.

[256]  H. Ågren,et al.  Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders. , 2000, Archives of general psychiatry.

[257]  The chronic mild stress procedure as an animal model of depression: valid, reasonably reliable, and useful , 1997, Psychopharmacology.

[258]  W. Kop.  Chronic and acute psychological risk factors for clinical manifestations of coronary artery disease. , 1999, Psychosomatic medicine.

[259]  N. Rothwell,et al.  Cytokines and the nervous system II: actions and mechanisms of action , 1995, Trends in Neurosciences.

[260]  R. Braith.  Exercise training in patients with CHF and heart transplant recipients. , 1998, Medicine and science in sports and exercise.

[261]  W. Chaplin,et al.  Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes. , 2006, American heart journal.

[262]  E. Emanuele,et al.  Increased plasma aldosterone in patients with clinical depression. , 2005, Archives of medical research.

[263]  B. Kupelnick,et al.  Improving compliance in depression: a systematic review of narrative reviews , 2006, Journal of clinical pharmacy and therapeutics.

[264]  Kenneth E Freedland,et al.  Depression, mortality, and medical morbidity in patients with coronary heart disease , 2003, Biological Psychiatry.

[265]  Abraham Weizman,et al.  Heart rate variability in patients with major depression. , 2004, Psychosomatics.

[266]  R. Davey,et al.  Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. , 1985, Annals of internal medicine.

[267]  Beretta-Piccoli,et al.  Plasma Catecholamines and Essential Hypertension An Analytical Review , 2005 .

[268]  Robert M Carney,et al.  Association of anxiety with reduced baroreflex cardiac control in patients after acute myocardial infarction. , 2002, American heart journal.

[269]  I. Heuser,et al.  Cerebrospinal fluid concentrations of corticotropin‐releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: Response to amitriptyline treatment , 1998, Depression and anxiety.

[270]  L. Lecea,et al.  Stress and arousal , 2005, Molecular Neurobiology.

[271]  R. Dantzer,et al.  Molecular Basis of Sickness Behavior a , 1998, Annals of the New York Academy of Sciences.

[272]  J. Gilmore,et al.  Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro , 1997, International Journal of Developmental Neuroscience.

[273]  R. Zoeller,et al.  Physical Activity: Depression, Anxiety, Physical Activity, and Cardiovascular Disease: What's the Connection? , 2007 .

[274]  A. Johnson,et al.  The Neuroendocrinology of Thirst and Salt Appetite: Visceral Sensory Signals and Mechanisms of Central Integration , 1997, Frontiers in Neuroendocrinology.

[275]  P. Honerjäger,et al.  The positive inotropic effect of aconitine , 1983, Naunyn-Schmiedeberg's Archives of Pharmacology.

[276]  G. Jennings,et al.  Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: Reduction by a selective serotonin reuptake inhibitor , 2007, Stress.